Promoting and facilitating strategies to improve cardiovascular health worldwide

ISCP Featured Sessions 2018

ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors



FDA designates recall of several implanted cardiac pacemakers as class 1

Posted on February 15, 2019

The FDA has designated Medtronic’s product recall of implanted cardiac pacemakers as a class 1 recall, the most serious kind. The recall... more

Higher push-up capacity decreases risk for CVD events

Posted on February 15, 2019

Patients with higher push-up capacity had a decreased risk for CVD events, according to a study published in JAMA Network Open.“Our findings... more

Common triggers for AF episodes modifiable

Posted on February 15, 2019

Common triggers for atrial fibrillation included caffeine, alcohol, lack of sleep and exercise, according to a study published in HeartRhythm.“Better understanding of... more

Bivalirudin, heparin equally effective in elderly patients undergoing CTO PCI

Posted on February 15, 2019

Among elderly patients at high bleeding risk undergoing PCI for chronic total occlusion, bivalirudin was as safe and effective as unfractionated heparin,... more

ISCP book series

Current Cardiovascular Therapy
Kaski, Juan Carlos.

Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...

  • Antiplatelet and Anticoagulation Therapy

    A. Ferro, D.A. Garcia (Eds.)

  • Pharmacological Treatment of Acute Coronary Syndromes

    Avanzas, Pablo; Clemmensen, Peter(Eds.)

  • Atrial Fibrillation Therapy

    Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)

board of directors

Providing a leadership and advocacy role amongst members of their national societies.


  • Augusto Gallino


    Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX (more…) more

  • Hector Ventura


    Affiliations/Memberships Section Head, Cardiomyopathy and Heart Transplant Director, Cardiovascular Disease Training Program (more…) more

  • Pablo Avanzas


    Affiliations/Memberships Consultant in Invasive Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Fellow of the European Society (more…) more

  • Thomas Kahan


    Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more